Article Details

Binge Eating Disorder Drug Market Investment Analysis | Roche, Chronos Therapeutics ...

Retrieved on: 2022-02-17 02:40:30

Tags for this article:

Click the tags to see associated articles and topics

Binge Eating Disorder Drug Market Investment Analysis | Roche, Chronos Therapeutics .... View article details on hiswai:

Excerpt

Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals, Opiant Pharmaceuticals, …

Article found on: sciencemarketnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up